In structure-activity relationship studies of N 3 -substituted oxopyrimidine nucleosides for sedative and hypnotic activities, we have found for the first time that N 3 -benzyl substituted uridine exerted a hypnotic action on mice by intracerebroventricular (i.c.v.) administration.
2) Among the uridine derivatives previously reported [3] [4] [5] [6] [7] [8] (uridine, 6-azauridine, thymidine, 2Ј-deoxyuridine derivatives), N 3 -phenacyluridine displayed the most potent hypnotic activity. Moreover, it was thought that the hydroxy group on the sugar (ribose) moiety plays an important role for the central nervous system (CNS) depressant effects. Since 2Ј,3Ј-O-isopropylideneuridine is protected at the 2Ј,3Ј-position hydroxy groups in the ribose moiety, it seems a useful lead compound to determine whether the sugar moiety in oxopyrimidine nucleoside derivatives imparts the CNS depressant effects. We thus synthesized various N 3 -substituted 2Ј,3Ј-O-isopropylideneuridine (1) derivatives and examined their CNS depressant effects.
Experimental
Animals Male std-ddY mice weighing 22 to 28 g were obtained from Sankyo Laboratories (Toyama, Japan). They were kept in an air-conditioned room (24Ϯ2°C) with controlled lighting (8:00 to 20:00 light period) and given food and water ad libitum. Experiments on hypnotic activity and pentobarbital-induced prolongation effects were carried out from 10:00.
Chemicals Sodium pentobarbital and halogenated alkyl compounds were purchased from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan).
Syntheses of N 3 -Substituted derivatives of 1 N 3 -Substituted derivatives of 2Ј,3Ј-O-isopropylideneuridine (1) were synthesized by the methods described previously. [2] [3] [4] [5] [6] [7] [8] [9] Briefly, 1 (1 mmol) dissolved in dimethylsulfoxide (DMSO) (3 ml) and acetone (3 ml) was refluxed at 80-90°C for 3 h with halogenated alkyls (1.0 mmol) in the presence of a base (K 2 CO 3 1.6 mmol). The product was purified by silica gel column chromatography with a solvent system of chloroform-ethyl acetate-methanol (5 : 4 : 1) and recrystallized except for oily substances. 
.).
Pharmacological Experiments Compounds tested were administered to mice by i.c.v. injection. Sleeping time was measured as the period between the loss and recovery of the righting reflex. The prolongation effects of N 3 -substituted 2Ј,3Ј-O-isopropylideneuridine on pentobarbital-induced sleep were assessed by the injection of sodium pentobarbital (40 mg/kg, i.p.) 15 min after administration of the test compounds. Spontaneous activity of mice was determined with an animal behavior analyzer equipped with an NEC PC-9801-RX microcomputer (Muromachi Ind., Tokyo) as described previously.
8) The statistical significance of difference between the control and test groups was performed by use of a one-way analysis of variance Student t-test.
Results and Discussion
Hypnotic activities of 1 and its N 3 -substituted derivatives are summarized in Table 1 . Compound 1, N 3 -methyl (2), propyl (4), butyl (5), allyl (6), benzyl (7), o-, m-, p-xylyls (8, 9, 10), and a-phenethyl (11) did not possess any hypnotic activity, as assessed by loss of righting reflex in mice, at the dose of 2.0 mmol/mouse by i.c.v. injection, whereas N 3 -ethyl (3) derivative possessed slight hypnotic activity (11 min) in mice at the same dose. Our previous work has shown that N 3 -alkyl substituted uridine, 6-azauridine, thymidine, and 2Ј-deoxyuridine do not exhibit any hypnotic activity in mice. [2] [3] [4] [5] [6] [7] [8] However, it was found that only 3 had CNS depressant effects among N 3 -alkyl substituted oxopyrimidine nucleosides tested. Amongst uridine derivatives, N 3 -alkyl substituted uridines did not exhibit any hypnotic activity, even at a high dose of 3.8 mmol/mouse by i.c.v. injection, while N 3 -benzyl, o-, m-, and p-xylyls, and a-phenylethyl substituted uridines displayed 36, 72, 56, 36, and 7 min of hypnotic activity at 2.0 mmol/mouse (i.c.v.), respectively. 4) In the present study, N 3 -benzyl, xylyls, and a-phenylethyl derivatives of 1 (7-11) did not have hypnotic activity, indicating that these derivatives display a different structure-activity relationship from the other N 3 -substituted oxopyrimidine nucleosides, presumably due to the lack of free hydroxy groups at the 2Ј-and 3Ј-positions of the sugar.
The effects of the derivatives of 1 on pentobarbital-induced sleep were also evaluated (Fig. 1). Compounds 1, 2 , 5-9, and 11 (2.0 mmol/mouse, i.c.v.) did not prolong pentobarbital-induced sleeping time, however, 3, 4, and 10 showed 167, 145, and 149% of control sleeping time (56Ϯ2 min) (Fig. 1) , respectively. The present results are not the same as found in N 3 -substituted oxopyrimidine nucleosides such as uridine, 6-azauridine, thymidine, and 2Ј-deoxyuridine which are not protected at the hydroxy groups of the sugar moiety. [2] [3] [4] [5] [6] [7] [8] The potent compounds 3 and 4 were also evaluated for spontaneous activity. Compounds 3 and 4 significantly decreased spontaneous activity to 6 and 20% of control levels (4505Ϯ560 cm/h) at the dose of 2.0 mmol/mouse, respectively. These results support the report by Krooth et al. 11) that oxopyrimidine nucleosides decreased mouse locomotor activity.
We previously reported that N 3 -benzyl-and benzyl-related derivatives of uridine, 6-azauridine, thymidine, and 2Ј-deoxyuridine possessed hypnotic activity in mice, suggesting that hydroxy groups on the sugar moiety of oxopyrimidine nucleosides play an important role in the CNS depressant effects. [2] [3] [4] [5] [6] [7] [8] In the present study, 7-11 did not exhibit hypnotic activity despite having benzyl, xylyl, or a-phenethyl groups at the N 3 position. The structure-activity relationships of 1 and its derivatives were different from series of oxopyrimidines previously reported. [4] [5] [6] [7] [8] These results indicate that hydroxy groups at the 2Ј and 3Ј positions of uridine may be important sites for CNS depressant effects of oxopyrimidine nucleosides. In addition, N 3 -ethyl and propyl-substitution of 1 caused CNS depressant effects. For this reason, it was hypothesized that the 2Ј,3Ј-Oisopropylidene moiety of 1 might stereospecifically interact with the N 3 -substituent. It is known that uridine is one of the pyrimidine nucleosides having a sleep-promoting effect in rats. 12, 13) Although 1 was not identified as a sleep substance, it appeared that 3, 4, and 10 exert CNS depressant activity. Thus, oxopyrimidines might play an important role in CNS regulation. However, the mechanism of the CNS depressant effects of oxopyrimidine nucleosides is still unknown. It is known that uridine interacts with g-aminobutyric acid (GABA) binding sites in the cerebellar membranes of the rat, 14) and we have recently reported that N 3 -phenacyluridine interacts with the benzodiazepine and uridine receptors.
15) The present results suggest that active and/or inactive derivatives of 1 may be useful as tools for study of the mechanism of CNS depressant effects of the pyrimidine nucleosides, as agonists and antagonists of these receptor ligands, respectively.
In conclusion, substitution with functional groups at the N 3 -position of the pyrimidine base and at the hydroxy groups of the sugar moiety could be an important factor for producing CNS depressant effects in oxopyrimidine nucleoside derivatives. 
